From May 2–5, 2026, members of the All Star Healthcare Solutions Gastroenterology team attended Digestive Disease Week® (DDW) — one of the largest and most influential gatherings in the field.
Across packed sessions, clinical discussions, and conversations throughout the exhibit halls, one message became increasingly clear: gastroenterology is entering a new era shaped by obesity medicine, precision therapies, AI integration, and earlier, more proactive approaches to patient care.
Rather than being defined by a single breakthrough, DDW 2026 highlighted a broader transformation happening across GI practice. Discussions repeatedly centered around how physicians can deliver more personalized, preventive, and technology-driven care while managing rising patient complexity and increasing demand.
From GLP-1 therapies and metabolic disease management to earlier intervention strategies in IBD and growing concerns around early-onset colorectal cancer, this year’s conference reflected how rapidly the field continues to evolve.
If you couldn’t attend DDW this year — or simply want the high-level trends that dominated conversations throughout the conference — here’s what stood out most.
How GLP-1 Therapies Are Changing Gastroenterology
Obesity medicine and incretin-based therapies remained some of the most discussed topics throughout DDW 2026.
While GLP-1 medications have already transformed weight management conversations, many sessions focused on how these therapies are fundamentally reshaping the role of gastroenterologists.
As incretin therapies increasingly overlap with MASLD/MASH management and endoscopic metabolic interventions, physicians discussed the growing convergence of obesity medicine, metabolic disease, hepatology, and GI care. Many conversations emphasized the expanding role gastroenterologists may play in long-term treatment coordination, screening, complication management, and multidisciplinary care models moving forward.
Among the emerging endoscopic approaches drawing significant attention was duodenal mucosal resurfacing, which was presented as a potential “off-ramp” strategy following GLP-1 therapy.
Key Takeaway: Obesity medicine is no longer adjacent to gastroenterology — it is becoming central to modern GI practice.
IBD Treatment Continues Moving Toward Earlier, Personalized Care
Inflammatory bowel disease remained another major focus throughout the conference, particularly as treatment strategies continue shifting toward earlier intervention and precision-based care.
Discussions highlighted the growing movement away from traditional step-up treatment approaches in moderate-to-severe disease. Instead, researchers and clinicians discussed earlier use of advanced therapies aimed at improving long-term disease control and patient outcomes.
Presenters also explored an expanding therapeutic pipeline that includes:
- New biologic and small-molecule therapies
- Combination treatment strategies
- Biomarker-driven treatment selection
- More individualized disease management approaches
As therapeutic options continue expanding, gastroenterologists are navigating increasingly complex decisions around treatment sequencing, long-term monitoring, and personalized patient management.
Key Takeaway: Treatment is becoming earlier, more targeted, and increasingly tailored to individual patient needs.
Rising Colorectal Cancer Rates in Younger Adults Remain a Major Concern
One of the most urgent conversations throughout DDW 2026 centered around the continued rise of colorectal cancer in younger adults.
Presentations throughout the conference highlighted research projecting that rectal cancer mortality in younger populations could continue rising faster than colon cancer mortality if current trends persist. Other sessions examined how early-life exposures, environmental factors, diet, and lifestyle patterns may be contributing to earlier disease development.
For many attendees, the rise in early-onset colorectal cancer represented one of the conference’s most significant public health concerns — particularly as physicians continue working to improve earlier detection and patient awareness.
Recurring themes across these discussions included:
- Greater awareness of early-onset colorectal cancer symptoms
- Earlier risk identification and symptom-triggered evaluation
- Prevention strategies that begin earlier in life
- Ongoing patient and clinician education
- Lower thresholds for referral and diagnostic workup in younger adults
Key Takeaway: Early-onset colorectal cancer is becoming an increasingly important focus across screening, prevention, education, and diagnostic evaluation in GI care.
AI and Precision Medicine Continue Expanding Across GI Care
Artificial intelligence was no longer discussed as a future concept at DDW 2026 — it was increasingly framed as a practical tool being integrated into real-world gastroenterology care.
Discussions explored patient-facing AI, predictive risk tools, and the growing role AI may play in shared decision-making and personalized care. Speakers also emphasized that successful AI adoption will depend on more than just accurate models. Workflow integration, physician oversight, patient understanding, and ethical implementation remained major themes throughout the conference.
Beyond AI, several sessions highlighted the broader shift toward more individualized and precision-based GI care. A presentation on pancreatic cyst diagnosis explored multimodal diagnostic approaches combining imaging, molecular testing, and endomicroscopy to improve accuracy and reduce unnecessary procedures.
Other sessions focused on IBS, SIBO, and chronic diarrhea management, where researchers emphasized moving beyond traditional trial-and-error treatment approaches toward more personalized diagnostic strategies.
Researchers also presented emerging microbiome data examining whether restoring a more youthful gut microbiome could potentially reduce liver aging and liver cancer risk in animal models — reinforcing continued interest in the microbiome as a future therapeutic target.
Key Takeaway: Gastroenterology continues moving toward more individualized, data-informed, and precision-based models of patient care.
The Bigger Picture Emerging from DDW 2026
Across nearly every specialty area, DDW 2026 reflected the same broader trend: gastroenterology is becoming more individualized, data-driven, and increasingly complex.
As therapeutic options expand and patient demand continues to rise, physicians are balancing growing procedural complexity, evolving technologies, higher patient expectations, and increasing pressure around outcomes and efficiency.
For many gastroenterologists, adapting to these changes may increasingly require broader clinical exposure, procedural diversity, and flexibility across different practice settings.
Advance Your Gastroenterology Career with Greater Flexibility
Locum tenens gastroenterologists are uniquely positioned to gain exposure to many of the clinical trends and evolving care models reshaping GI practice today while also helping health systems address growing patient demand and coverage needs.
From advanced endoscopy programs and complex IBD management to emerging metabolic therapies and evolving diagnostic technologies, locum opportunities can offer valuable clinical variety, schedule flexibility, and career mobility.
At All Star Healthcare Solutions, our specialized Gastroenterology team partners with physicians nationwide to help them explore opportunities aligned with their professional goals while continuing to deliver high-quality patient care.
Missed us at DDW 2026?
You can still connect with our team — submit your CV to get started, explore our open gastroenterology opportunities nationwide, or stay informed with our latest Gastroenterologist Salary Guide.
Data Sources Cited
- Obesity Pharmacotherapy Enters a New Era as Incretins Reshape Treatment
- Too Common to Refer Away: The Urgency of MASLD/MASH for GI Practitioners
- Duodenal Mucosal Resurfacing Shows Promise as Post–GLP-1 “Off-Ramp” Strategy
- Advanced Therapy Should Be the Default at Diagnosis for Moderate to Severely Active IBD
- Building the Arsenal to Fight IBD: New Drugs, Precision Medicine and Combinations
- Rectal Cancer Deaths Set to Outpace Colon Cancer Deaths in Young Adults
- Early Life, Lasting Risk: Rethinking the Timing of Colorectal Cancer Risk Factors
- Patient-Facing AI: Validation, Interpretation, Ethics and Workflow
- Putting the Pieces Together to Solve the Puzzle of Pancreatic Cyst Diagnosis
- Moving Beyond the “Fishing Expedition” in Chronic Diarrhea
- The Science of IBS and SIBO: Emerging Tools Refine Diagnosis and Personalize Care
- Restoring a Youthful Gut Microbiome Prevents Liver Cancer and Reverses Hepatic Aging in Mice